Search | Clinical Trials Finder

Conditions: Conduct Disorder, Oppositional Defiant Disorder, Attention Deficit Disorder With Hyperactivity
Interventions: Community mental health consultation model program, Treatment as usual (TAU); Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 5 Years to 12 Years
Enrollment: 482 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Posttraumatic Stress Disorder, Complex Post-Traumatic Stress Disorder
Interventions: Not listed
Lead sponsor: Cambridge Health Alliance; Other
Eligibility: 18 Years to 75 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Malden, Massachusetts

Conditions: Pediatric Obesity, Sedentary Behavior
Interventions: Garden installation; Other
Lead sponsor: North Carolina State University; Other
Eligibility: 42 Months to 6 Years
Enrollment: 286 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 15
States / cities: Cary, North Carolina • Fuquay-Varina, North Carolina • Knightdale, North Carolina + 2 more

Conditions: Violence, Substance Use, Criminal Behavior, Violence in Adolescence
Interventions: Remote Therapy Intervention (RTI), Artificial Intelligence Remote Therapy Intervention; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 14 Years to 24 Years
Enrollment: 584 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 4
States / cities: Atlanta, Georgia • Detroit, Michigan • Flint, Michigan + 1 more

Conditions: Breast Cancer
Interventions: Chatbot; Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2,700 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Pediatric Iron Deficiency, Anemia
Interventions: choline bitartrate, placebo drug; Drug · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 5 Months to 7 Months
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Substance Use Disorder (SUD)
Interventions: Not listed
Lead sponsor: Evidation Health; Industry
Eligibility: 21 Years and older
Enrollment: 1,910 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: San Mateo, California

Conditions: Nutrition Disorders
Interventions: Educational Tool, PALS, WebMD; Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Stroke
Interventions: TPAD (Tethered Pelvic Assist Device); Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Bilateral Hearing Loss, Health Services Research
Interventions: Pharmacy Technician Educational Training; Behavioral
Lead sponsor: University of Alabama, Tuscaloosa; Other
Eligibility: 18 Years and older
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Tuscaloosa, Alabama

Conditions: Improving Blood Pressure Control
Interventions: CONTROL- Usual & Customary Health Fair Follow-up, Health Fair + TECH [Text Messaging + Home Blood Pressure Monitoring], Heal th Fair + TECH [Text Messaging + Home Blood Pressure Monitoring] + Social Network Support (SNS); Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 21 Years and older · Male only
Enrollment: 166 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy Volunteer Study, Healthy Adults, Healthy Participants, Asthma
Interventions: PF-08103402, Placebo, Midazolam; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 133 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Autism Spectrum Disorder
Interventions: TEACCH School Transition to Employment and Postsecondary Education (T-STEP), Counseling Services Alone; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 16 Years to 21 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 5
States / cities: Chapel Hill, North Carolina • Clayton, North Carolina • Graham, North Carolina + 2 more

Conditions: Advanced Solid Tumors
Interventions: BAY2965501, Pembrolizumab, Platinum-based Chemotherapy; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 284 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: Denver, Colorado • Pittsburgh, Pennsylvania • San Antonio, Texas

Conditions: Multiple Sclerosis
Interventions: Balance Training; Behavioral
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Behavior, Depressive Disorder, Anxiety Disorders, Obsessive Compulsive Disorder (OCD)
Interventions: Behavioral task performance; Behavioral
Lead sponsor: California Institute of Technology; Other
Eligibility: 18 Years to 65 Years
Enrollment: 1,100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Los Angeles, California • Pasadena, California

Conditions: Type 2 Diabetes
Interventions: Family Model Diabetes Self-Management Education and Support; Behavioral
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 321 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Springdale, Arkansas

Conditions: Melanoma
Interventions: Fianlimab+cemiplimab; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 10
States / cities: Los Angeles, California • San Francisco, California • Aurora, Colorado + 7 more

Conditions: Stroke, Acute
Interventions: External Focus of Attention, Internal Focus of Attention; Other
Lead sponsor: Western Carolina University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Asheville, North Carolina • Cullowhee, North Carolina

Conditions: Prevention of Stroke or Systemic Embolism, Atrial Fibrillation
Interventions: Asundexian (BAY2433334), Apixaban, Asundexian matching placebo, Apixaban matching placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 14,830 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 163
States / cities: Dothan, Alabama • Fairhope, Alabama • Mobile, Alabama + 144 more

Conditions: Dementia, Cognitive Decline, Cognitive Impairment, Developmental Delay
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Infant Obesity, Parenting, Feeding Behavior
Interventions: Responsive Feeding Training; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 3 Months to 9 Months
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Treatment of Bleeding, Prophylaxis of Bleeding, Hemophilia A, Children
Interventions: Damoctocog alfa pegol (Jivi, BAY94-9027); Biological
Lead sponsor: Bayer; Industry
Eligibility: 7 Years to 11 Years · Male only
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Type 1 Diabetes
Interventions: AID + InsuLearn-SMA, AID + CC; Device
Lead sponsor: Melissa J. Schoelwer; Other
Eligibility: 14 Years to 21 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Charlottesville, Virginia

Search by objective public record fields.

School-Based Mental Health Services for Urban Children

Using Data Science To Center Patient Perspectives in Mechanism Discovery

Childcare Outdoor Learning Environments as Active Food Systems

Using Re-inforcement Learning to Automatically Adapt a Remote Therapy Intervention (RTI) for Reducing Adolescent Violence Involvement

Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study

Choline and Iron Deficiency

Research and Engagement on Substance Use: Harnessing Awareness and Personalized Education (RESHAPE) to Improve Well-being and Self-efficacy

PALS for Nutrition Education

Reducing Asymmetry During Gait Using the TPAD (Tethered Pelvic Assist Device) for Stroke Patients

Assessing Pharmacy Technician Educational Training for the Provision of Over-the-Counter Hearing Aids in Rural Alabama and Mississippi Pharmacies

Taxi METERS: Measuring Effectiveness of Technology, Education, Referrals and Support

A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma

Examining the Efficacy of the T-STEP

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Brain and Behavioral Influences on Motor Skill Learning in Multiple Sclerosis

Can Computational Measures of Task Performance Predict Psychiatric Symptoms and Changes in Symptom Severity Across Time

Family Model Diabetes Self-Management Education in Faith Based Organizations

A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment

FOA on Sit to Stand in Individuals Post Stroke

A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke

Ammonia Levels and Cognitive Impairment

Learning to Love Mealtime Together

A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood

Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery